Home LiteratureArticle Details
PMID: 3947331 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Phenyl-n-butylborinic acid is a potent transition state analog inhibitor of lipolytic enzymes.

Biochemical and biophysical research communications ·Vol. 134 ·No. 1 ·1986-01-14 ·Pages 386-92

Sutton LD, Stout JS, Hosie L, Spencer PS, Quinn DM

Abstract

The cholesterol esterase and lipoprotein lipase catalyzed hydrolyses of the water-soluble substrate p-nitrophenyl butyrate are competitively inhibited by butaneboronic acid and phenylboronic acid. Phenyl-n-butylborinic acid has been synthesized and characterized as an ultrapotent transition state analog inhibitor: Ki = 2.9 +/- 0.6 nM and 1.7 +/- 0.3 microM for the cholesterol esterase and lipoprotein lipase reactions, respectively. These results are interpreted in terms of transition state structure and stabilization.

MeSH Terms
Animals Borinic Acids/pharmacology Boron Compounds Boronic Acids/pharmacology Butyrates/pharmacology Kinetics Lipolysis/drug effects Lipoprotein Lipase/metabolism Mathematics Sterol Esterase/metabolism Swine
Chemicals
Borinic Acids Boron Compounds Boronic Acids Butyrates phenyl-n-butylborinic acid 4-nitrophenyl butyrate n-butylboronic acid Sterol Esterase Lipoprotein Lipase benzeneboronic acid
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Sutton L D
Stout J S
Hosie L
Spencer P S
Quinn D M
Article Info
Journal
Biochemical and biophysical research communications
Abbr.
Biochem Biophys Res Commun
ISSN
0006-291X
Published
1986-01-14
Pages
386-92
Language
English
Region
United States
NLM ID
0372516
Subset
IM
Grants
NHLBI NIH HHS · HL10583 · United States
NHLBI NIH HHS · HL30089 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]